FDAMA's PMA Data Use Provision Not Retroactive, HIMA Tells FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA Modernization Act language allowing use of data from approved premarket approval applications should not be applied retroactively to existing PMAs, the Health Industry Manufacturers Association holds in a March 1998 position paper.